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Fabrication of the Microfluidic Device. Microchannels were fabricated as described before. [1] Briefly, microchannels with rectangular cross section were obtained by rapid prototyping in poly(dimethylsiloxane) (PDMS). The PDMS/PDMS devices were sealed using Plasma Prep II plasma cleaner. After sealing, we rendered the microchannels hydrophobic by baking the PDMS devices in a 120°C oven for over one hour.
ThT Aggregation Assay. A 40 (NH 2 -DAEFR 5 HDSGY 10 EVHHQ 15 KLVFF 20 AEDVG 25 SNKGA 30 IIGLM 35 VGGVV 40 -COOH) was obtained from rPeptide. HiLyte and fluorescein labeled A 40 were obtained from Anaspec. To dissolve preformed peptide aggregates of A 40 , the lyophilized peptide was first dissolved in hexafluoroisopropanol (HFIP). The HFIP was evaporated from the samples of peptides, and the samples were then dried under a high vacuum overnight. The concentration of the solution of peptides was determined by absorbance at 280 nm using an extinction coefficient of = 1360 M -1 cm -1 for Tyr. A 40 was dissolved in water shortly before use. Aggregation of A 40 was detected by Thioflavin T (ThT) fluorescence. [2] Aggregation experiments in a well plate were done on a Polarstar Omega (BMG Labtech). For this we used 50 µM A 40 and 50 µM ThT dissolved in 50 mM Tris (pH 7.3) at 37°C.
Microfluidic Experiment. Aqueous and fluorous solutions were filled into 10 µL gastight syringes (Hamilton Company), which were then connected to the microfluidic device by 30-gauge Teflon tubing (Weico-Wire & Cable). For A 40 and CSF solutions, we filled the syringes with flourocarbon and aspirated 2 µL of either solution into Teflon tubing, which was then connected to a syringe and a PDMS device. Syringes were driven by PHD 2000 Infusion pumps (Harvard Apparatus). We used Fluorinert FC-40 or FC-70 (3M), purified by distillation before use, as a carrier fluid.
The fluoro-surfactant 2-{2- [2-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9- Heptadecafluoro-nonyloxy)-ethoxy]-ethoxy}-ethanol (R f -OEG 3 ) was synthesized as described elsewhere. [3] (2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9- Heptadecafluoro-nonyloxy)-ethoxy]-ethoxy}-ethanol (R f -OEG 3 ).
1) Determination of the Concentration of A 40 in Plugs. To verify that A 40
was encapsulated in plugs without nonspecific adsorption to PDMS or other interfaces, we encapsulated various concentration of fluorescein-labeled A 40 in plugs. Additionally, we recorded a standard curve with fluorescein (dissolved in 0.05% NH 4 OH) encapsulated in plugs. Figure formed, the syringes were disconnected and the flow was stopped. To avoid evaporation of water from the plugs during the experiments, the plugs within the Teflon tubing were inserted into oil filled glass capillaries, and then the capillaries were sealed with sealing wax. Next, the capillaries were incubated at constant temperature (37°C), and the ThT fluorescence of the plugs was measured periodically.
3) Cerebrospinal Fluid Titration Experiments (figure 2).
All animal experiments and protocols were approved by and conducted according to institutional and NIH guidelines. CSF was isolated from the cisterna magna compartment as previously described. [4] In brief, mice were anesthetized with a mixture of ketamine and xylene. An incision was made from the top of the skull to the dorsal thorax, and the musculature was removed from the base of the skull to the first vertebrae to expose the meninges overlying the cisterna magna. The tissue above the cisterna magna was excised. A microneedle was used to punctuate the arachnoid membrane covering the cistern. The CSF, which is under positive pressure as a result of blood pressure, respiration, and positioning of the animal, began to flow out of the needle entry site once the needle was removed. The fluid was then collected using a polypropylene narrow bore pipette as it exited the compartment.
Experiments with mouse CSF were done using a five-channel inlet device, where (1) A 40 , (2) buffer, (3) ThT in a salt solution, (4) CSF, and (5) FC-40 with 1.25 mg/ml R f -OEG 3 , were each allocated to one channel. The contact of CSF and A 40 to PDMS is avoided in all titration experiments by inserting teflon tubing in the inlet channels of the solutions up the junction were plug formation takes place (see figure 2a) . In order to screen the inhibitory potency of CSF on A 40 , we performed three experiments for each mouse CSF sample with three different pre-dilution factors of CSF (1:10, 1:5 and 1:1). Dilutions of CSF were done with a buffer that contained 150 mM NaCl and 10 mM PO 4 2-pH 7.3 at 37°C. Further dilutions (1:20, 1:10, 1:5, 1:4, and 1:2.5) of the pre-diluted samples were obtained by changing the flow rates of the aqueous streams. The flow rate ratio of the total aqueous phase and the FC-40 phase was kept constant (2µL min -1 /2µL min -1 ). The flow rate of the A 40 and ThT/salt solution were also kept constant. Only the flow rates of the buffer and CSF streams were changed to counteract each other. The length of the tubing used as a cartridge was matched with the total pumped volume in a titration experiment. The typical length of one condition filled approximately 6 cm of the cartridge. Plugs with the same condition in the cartridge were retrieved by calculating the position from the volume to length dependence. The cartridge tubing was placed in a PDMS mold (400 µm in width and 3 cm in length) and sealed to a glass slide (see figure 2a ). Transitions between the two conditions were programmed to be located in the loop regions.
Images of plugs were taken only in the region 1.5 cm from the starting and ending point of a single condition (i.e images only of plugs located in the PDMS mold).
Although the position of the transition can vary between experiments (± 0.5 cm), 1.5 cm buffer volume on each side was sufficient to avoid shifts between the conditions (see SI- Fig.3) . The pumps during a titration experiment were controlled with a LabView program. We also confirmed that increasing the ionic strength of the buffer is responsible for nucleating A 40 in plugs without a lag time. For this we measured the aggregation kinetics of A 40 in dilutions of the above described buffer (1:1, 1:2, and 1:4) . Figure   SI-4 shows the effect of the salt concentration on A 40 aggregation kinetics. 
TTR Titration Experiment
Titration experiments with TTR were performed under the same conditions as described for CSF experiment. Human TTR cDNA representing the mature protein without the endoplasmic reticulum-targeting signal sequence was inserted into the bacterial expression vector pProEx-HTa using standard molecular biology techniques. 
